US And Japan Cause A Slip In Value-Added Market

 
• By Aidan Fry

Difficulties in the US and Japan have stalled growth in the global value-added medicines market. But a coming wave of digital therapeutics promises to revive the market.

Add_Value
Global sales of added-value medicines have stalled, but digital therapeutics could revive growth • Source: Shutterstock

More from Value Added Medicines

More from Products